This morning, for the first time in 37 years, United States Surgeon General Jerome M. Adams issued a Surgeon General's Advisory on marijuana, becoming the first Surgeon General to do so since former Surgeon General C. Everett Koop's in 1982.
Joined by U.S. Department of Health and Human Services Secretary Alex Azar, Assistant Secretary for Health Admiral Brett Giroir, Assistant Secretary for Mental Health and Substance Use Dr. Elinore F. McCance-Katz, and Director of the National Institutes of Health (NIH) National Institute on Drug Abuse Dr. Nora D. Volkow, Surgeon General Adams hosted a national press conference to share the details of his Advisory on Marijuana Use and the Developing Brain. During the press conference, Surgeon General Adams urged health leaders and prevention advocates to convey that "no amount of marijuana use during pregnancy or adolescence is safe."
In his Advisory, Surgeon General Adams asserts that "marijuana can impair learning in adolescents," with chronic marijuana use "linked to declines in IQ and school performance that jeopardizes professional and social achievements and life satisfaction." He goes on to emphasize that "marijuana use is also linked to risk for and early onset of psychotic disorders, such as schizophrenia" and "adolescent marijuana use is often associated with other substance use."
General Arthur T. Dean, CADCA's Chairman & CEO, was invited to attend the press conference, and his thoughts on the advisory are included in a press release issued today by CADCA. General Dean believes that "...in accordance with the science and medical research developed by NIH and endorsed by Surgeon General Adams, adolescent marijuana use is unsafe and can have extremely detrimental effects on the developing brain."